Get Started

KPTI

NASD Karyopharm Therapeutics, Inc.
Oct 31, 2026 · 1:18 PM ET EOD Market Closed

$0.6620 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.6620, $0.2400 below the day’s high of $0.9020

YTD change
-91.01%
vs 20-day SMA
+22.28%
vs 200-day SMA
-89.09%

Price ranges

Previous day
$0.5842 $0.9020
open $0.9020 close $0.6620
-$0.2400 (-26.61%)
Today
$0.5842 $0.9020
$0.6620
Past week
$0.4224 $0.9869
from $0.5461 now $0.6620
+$0.1159 (+21.22%)
Past month
$0.3100 $0.9869
from $0.8668 now $0.6620
-$0.2048 (-23.63%)
This year
$0.3100 $10.9900
from $7.3600 now $0.6620
-$6.6980 (-91.01%)

Price & Performance

-8.11 (-92.45%) / 6M

$-0.5134$3.49$7.49$11.50May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.9% away from all-time highs of $444.1500
  • KPTI is down 91% since the beginning of the year
  • KPTI is down 89% over the past 12 months
  • KPTI is down 24% over the past 1 month
  • 40% of all KPTI investors are betting against KPTI

KPTI reads not so good: price sits above one of the two key moving averages, the 12-month move is -88.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-2.32
Earnings momentum -145.2% Quarterly EPS growth
Quarterly change -145.2%

Valuation

P/E ratio N/A
Enterprise value $216.5M
Beta 2.89

Balance sheet & scale

IncomeN/A
Revenue$146.6M
Cash$65.1M
Debt$256.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $15.0M

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $927.89 +13.33%
IQV IQVIA Holdings Inc $267.33 -2.81%
CRL Charles River Laboratories International, Inc. $359.41 -4.44%
ICLR ICON Plc $211.36 -1.91%
IT Gartner, Inc. $228.79 +1.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.